An association between the metabolic syndrome (MetS) and chronic inflammatory diseases, such as psoriasis or rheumatoid arthritis, has been suggested. Hidradenitis suppurativa (HS), a more localized chronic inflammation of the skin, has been speculated to have a similar association. Hidradenitis suppurativa is a substantial burden for the individual and a socioeconomic burden globally. Information about the burden of possible comorbidities is scarce.
of HS is often inadequate, and the disease inflicts a significant burden on patients, in whom pain and suppuration from lesions often lead to inactivity, depression, and significantly impaired quality of life. 3, 4 Changes in patients' socioprofessional activity indicate the presence of important diseaserelated impairment. 5, 6 Hidradenitis suppurativa may be more common than hitherto suggested. The disease is often misdiagnosed or underdiagnosed, and prevalence estimates therefore range from 0.05% to 4%. [7] [8] [9] [10] An increasing incidence during the last 20 years has been suggested. 11 The comorbidities of HS are poorly described, and the available data are solely hospital based. 12, 13 The pandemic cluster of cardiovascular risk factors called the metabolic syndrome (MetS) co-occurs more commonly with chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis. [14] [15] [16] [17] [18] In contrast to psoriasis, HS may be considered a more localized inflammation of the skin. An association between HS and MetS has been hypothesized to exist and cause significant comorbidity, negatively influencing the overall burden of disease. We therefore investigated a possible association using population-and hospital-based data in a cross-sectional study to explore the association and assess its possible clinical relevance.
Methods

Ethical Statement
This study was accepted by the ethics committee of the Zealand region (project numbers SJ-191, SJ-113, and SJ-114) in Denmark. Written informed consent was obtained from all study participants.
Study Design
We performed a cross-sectional study of the association of HS (referred to as the exposure) and MetS (referred to as the outcome). We investigated 2 different groups of individuals with HS. The first group was identified in a general population sample (population HS group); the second was identified in a hospital-based sample (hospital HS group).
Exposure
The population HS group was identified in the Danish General Suburban Population Study (GESUS). GESUS was initiated in January 2010 with ongoing enrollment and is a crosssectional study of the adult Danish suburban general population in the Naestved municipality (70 km south of Copenhagen). 19 All citizens 30 years and older and a random selection of those aged 20 to 30 years were invited to participate. The population HS group was defined based on whether participants reported boils within the previous 6 months and a minimum of 2 boils (in the following 5 possible locations: axillae, groin, genitals, mammae, or other [eg, perianal, neck, or abdomen]) on a questionnaire. The validation of this HS diagnosis is discussed in a separate report 5 showing a sensitivity of 90% and a specificity of 97%. The overall participation rate in GESUS was 49.3%. Further details about GESUS can be found in Bergholdt et al. 19 The hospital HS group was recruited from the outpatient clinic at the Department of Dermatology at Roskilde Hospital (serving the region of Zealand, which includes Naestved). Inclusion criteria consisted of the diagnostic code for HS from the International Classification of Diseases, 10th Revision (L73.2) and systemic or laser treatment for HS, which indicated moderate or severe disease. The diagnosis of HS was confirmed by results of a physical examination by a physician from the Department of Dermatology (I.M.M., G.R.V., K.Z., or K.S.I.). Eligible patients were invited to undergo the same examination as the population sample. The participation rate was 33 of 98 eligible patients (33.7%). The distribution of age and sex did not differ between participants and nonparticipants (data not shown).
Non-HS participants were defined as participants from GESUS without HS. This population constituted the non-HS group for this study.
Outcomes
Both HS groups and the population-based non-HS group completed the same questionnaire and physical examinations and contributed blood samples. The definitions of the MetS outcome were based on the methods of GESUS involving the GESUS questionnaire (self-reporting), physical examination, and laboratory evaluation of nonfasting venous blood samples.
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The MetS involves the following 4 key components: diabetes mellitus, hypertension, dyslipidemia, and obesity. The methods of this study used to define the outcome are listed in Box 1 and Box 2. 
Exploring Possible Confounders
We considered the following possible confounders: 1. General obesity defined by body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) measured at the physical examination; 2. Inflammatory load defined by high-sensitivity C-reactiveprotein level measured in venous blood samples; 3. Self-reported level of physical activity at work and in leisure time; 4. Self-reported intake of atherogenic (ie, saturated) fat, fish, fruit/vegetables, eggs, and alcohol.
Exploring the Severity of HS
The definition of severity of HS for the population HS group was based on self-reported information on numbers and locations of boils and subsequent scarring and was inspired by the Hurley score, which is considered almost static.
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Mild HS was defined as a minimum of 2 boils and no subsequent scarring; moderate HS, a minimum of 2 boils and subsequent scarring; and severe HS, a minimum of 2 boils in a minimum of 2 locations and subsequent scarring. The
Statistical Analysis
We compared the HS and non-HS groups using logistic regression adjusting for age, sex, and smoking status, yielding an adjusted odds ratio (OR) for binary outcomes, and linear regression of log-transformed outcomes adjusting for age, sex, and smoking status, yielding an adjusted ratio of means (RM) for continuous outcomes. We examined the influence of possible confounders on the association between HS and MetS by including these in the regression model and assessing the effect on the OR. We explored the relationship between the severity of HS and MetS using the same regression method as above analyzing only the HS groups. All statistical analyses were performed using commercially available software (SAS, version 9.3; SAS, Inc). Owing to differences in background factors between exposed and unexposed groups and knowledge from previous studies that age, sex, and smoking status act as confounders in cardiovascular risk, the effect measures were adjusted accordingly. In eTables 1 and 2 in the Supplement, crude ORs and RMs are displayed.
Results
The data used from GESUS were collected from January 1, 2010, through August 2, 2012. A total of 32 individuals with HS from the hospital, 326 with HS from the general population, and 14 851 non-HS individuals from the general population were identified. The background factors and characteristics of the HS and non-HS groups showed that individuals with HS were predominately younger, female, and smokers (Table) .
We investigated the association of HS with the conditions involved in the MetS-diabetes mellitus, hypertension, dyslipidemia, and obesity-and with MetS defined by the criteria of the National Cholesterol Education Program Adult Treatment Panel III. 20 The methods used to define the outcome are described in Box 1 and Box 2. The ORs and RMs adjusted for age, sex, and smoking status are illustrated in Figure 1 and Figure 2 . pressure was significant, with a level 5% (95% CI, 1%-10%) higher in the HS hospital group when compared with the non-HS group. When we quantified the association, the RM hos for BMI was 21% (95% CI, 14%-29%) and the RM pop was 9% (95% CI, 7%-11%), significantly higher for the HS groups than the non-HS group. The RM hos for WC was 14% (95% CI, 9%-19%) and the RM pop was 7% (95% CI, 6%-9%), significantly higher for the HS groups than the non-HS group.
Association of MetS and MetS Components With HS
Role of Obesity, Inflammatory Load, Physical Activity, Diet, and HS Severity When exploring the possible confounders, we found that adjusting for obesity or inflammatory load reduced the strengths of the associations; however, the associations remained. Thus, obesity and inflammation were identified confounders, whereas level of physical activity and diet were not (eTable 3 in the Supplement). The association between HS and MetS or between HS and the MetS components was not influenced by the degree of HS severity with the exception of general obesity (eTable 4 in the Supplement).
Discussion
This broad population-and hospital-based study suggests an association between HS and MetS and the individual MetS components of diabetes mellitus, low levels of HDL, and general and abdominal obesity. Positive associations were also found with regard to hypertension and dyslipidemia. Hypertension, however, was only statistically significant in the hospital HS group. When we used binary data (with acknowledged cutoff values) for increased levels of TG, only the association for the population HS group was statistically significant. However, statistically significant differences in the TG levels between the hospital HS group and the non-HS group were found when we examined the continuous data.
The hospital HS group had uniformly higher ORs than the population HS group. This result could indicate that differences in HS severity or the recent suggestion of different HS subtypes may play a part. 26 This difference might also be an expression of a dilution of the population-based HS sample due to misclassification bias. The stronger ORs for the hospital HS group may also indicate detection bias; that is, HS patients within the hospital system are more likely to have been diagnosed with the outcome, which influences the self-reported diagnoses. However, detection bias was minimized by the inclusion of self-reported diagnosis and results of the physical examination and laboratory analysis of blood samples. When we examined the MetS components individually, the ORs for diabetes mellitus indicated a positive association, mainly due to type 2 diabetes mellitus. Quantification analysis demonstrated that nonfasting glucose level was 1% to 8% higher, and hemoglobin A 1c level was 1% to 10% higher in the HS groups compared with the non-HS group. Previous studies have suggested that an approximately 1% reduction in hemoglobin A 1c level may decrease the risk for myocardial infarction by 14% to 16%, indicating that the abnormalities seen in the HS patients have clinical significance. 27 Further indirect support for this association is provided by the observation that metformin hydrochloride treatment may ameliorate HS. Furthermore, the ORs for general and abdominal obesity were significant. When quantified, BMI was 9% to 21% greater, and WC was 7% to 14% larger in the HS groups than the non-HS group. Trimming of the WC by 4.4 cm from 102 cm (ie, a 4.3% reduction) may reduce the risk for diabetes mellitus by 58%, similarly indicating clinical relevance and a substantial potential for prevention in this generally neglected disease. 29 The association of an atherogenic lipid profile (ie, increased TG levels and decreased HDL levels) was significant with regard to the decrease in HDL levels in both HS groups, but only significant with regard to the increase in TG levels in the population HS group. When quantified, the HS groups had an 11% to 21% higher TG level and a 10% to 14% lower HDL level than the non-HS group. A follow-up study of the effects of statins in 17 802 healthy individuals showed a significant reduction of cardiovascular events when TG levels were reduced by 17% and HDL levels were increased by 4%.
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Having hypertension was only significant with regard to the hospital HS group. When quantifying the hospital HS group, only the diastolic blood pressure was significantly increased by 5%. A recent meta-analysis of preventive treatment of hypertension suggested that lowering diastolic blood pressure from 90 to 85 mm Hg (ie, a 6% reduction) would reduce the risk for cardiovascular heart disease and stroke by approximately 20% and 30%, respectively.
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Our findings are in concordance with and expand the findings of 2 previous hospital-based studies. 12, 13 In aggregate, these data therefore suggest that the comorbidities of HS are clinically significant and that an increased clinical awareness of the HS diagnosis and its comorbidities might be warranted in this potentially substantial group of patients. Obesity and inflammatory load were identified as possible confounders, partly but not exclusively explaining the associations and indicating a complex and overlapping relationship. Surprisingly, we found that physical activity level, diet and alcohol consumption, and the severity of HS did not influence the associations. The latter is in contrast to our supposition that the hospital HS group had higher ORs because of more severe disease, implying detection bias as previously discussed or an insufficiently sensitive measure of disease severity. Therefore, one can speculate that HS subtypes may influence the association with MetS more strongly than HS severity.
The association of MetS has also been shown in the chronic generalized inflammatory disease rheumatoid arthritis and the skin disease psoriasis, for which the ORs for MetS are approximately 2.00 compared with almost 6.00 in HS. 8 Furthermore, the associations in psoriasis have been suggested to be significant only with regard to a hospital-based HS cohort, 8 implying that the burden of these comorbidities is greater for HS than for psoriasis. Therefore, the common etiological factors between inflammatory skin disease and MetS are more readily identified in HS than in psoriasis. The major strengths of our study are the large populationbased HS group and the inclusion of individuals with HS from hospital-and population-based groups. The broad recruitment reduced selection bias with a broader range of disease severities and thereby aided the generalization of the results. To explore misclassification bias of individuals with HS, we vali- dated the HS definition with a sensitivity of 90% and a specificity of 97%. 9 Because the self-reported questions used to identify HS patients refer to symptoms (ie, boils) rather than the actual diagnosis (ie, do you have HS?), we strove to optimize the inclusion of individuals with undiagnosed and misdiagnosed HS in the population, which is particularly pertinent for underdiagnosed diseases. The diagnosis of HS among hospitalized participants was physician verified. The combined methods of selfreporting, laboratory analysis of blood samples, and physical examination aimed to reduce false-negative findings with regard to the outcome (MetS). Finally, essential possible confounders were recognized and explored systematically. Potential limitations merit consideration. First, one must recognize that, because this study is cross-sectional, we cannot prove causality between HS and MetS. Furthermore, the population is suburban, most of the participants were white, and the group aged 20 to 30 years was underrepresented, which may limit the generalizability of our findings. In addition, an age bias was found between the HS and non-HS groups. However, we accommodated this age bias by age adjustments. The low participation rate of the hospital HS group increased variation and reduced power. The low participation rate may be an expression of the limited resources of HS patients due to the physical and mental burden of the disease. Nonfasting blood samples were used. However, differences in fasting and nonfasting lipid levels have been shown to be minimal. 32 Furthermore, we did not include information on HS medical treatment, which might confound the results. Last, as with any questionnaire survey, the risk for recall bias was present.
Conclusions
The data suggest an association between HS and the MetS in the hospital and population HS groups. This allegedly increased disease burden due to comorbidities indicates that HS patients require general medical attention beyond the skin. Future longitudinal studies with similar methods are needed to explore the temporal relationship of these associations. These studies should be large, include individuals with HS from the general population and hospital, and explore the differences between these groups and additional possible confounders.
Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. 
NOTABLE NOTES
Apple of the Dermatologist's Eye
Deshan F. Sebaratnam, MBBS(Hons)
Dermatology is an intrinsically visual specialty, with pattern recognition a vital skill for clinical practice. It therefore follows that many of the classic descriptions of cutaneous pathologic abnormalities draw on parallels from the natural world, particularly the realm of botany. Trees, leaves, fruits, and flowers have all lent themselves to morphological descriptions over the centuries.
The distribution of the papulosquamous plaques of pityriasis rosea has been compared to a fir tree and the hair shaft changes of trichorrhexis nodosa to bamboo. The figurate polycyclic plaques of erythema gyratum repens have been described as resembling wood grain and the jagged forked lesions of livedo racemosa tree branches. 1 The induration associated with scleroderma is classically described as woody, and the neurofibromas of neurofibromatosis are said to have a rubbery consistency. Lichenification derives its name from lichen (a composite organism of fungi and algae living symbiotically), and the tumors of mycosis fungoides were initially thought to be fungal growths (though strictly speaking, the kingdom of Fungi is separate from that of plants).
The ovate shape of the hypopigmented macules of tuberous sclerosis has been compared to ash leaves, and the color of Zoon balanitis has been described as resembling that of fallen autumn leaves.
Fruits have inspired a range of dermatological descriptions, including peau d'orange, tapioca vesicles in pompholyx, and cayenne pepper spots in pigmented purpuric dermatoses. The berries are particularly well represented through strawberry birthmarks, mulberry xanthomas, and cherry angiomas.
Flowers have also given rise to dermatological descriptions, such as the heliotrope rash of dermatomyositis, which originates from the lilac color of flowers of the genus Heliotropium. 2 Perhaps the plant that has inspired the greatest number of wordsmiths within dermatology and beyond is the rose. Varicella zoster virus gives rise to "dew drops on a rose petal," human herpes virus is associated with roseola infantum, and Salmonella typhi produces rose spots. The rosette is a well-recognized sign reported in a range of descriptions: clinically, as in linear IgA disease; dermoscopically, as in squamous cell carcinoma 3 ; and pathologically, as in cylindromas.
The visual nature of dermatology lends itself to comparisons between cutaneous pathological abnormalities and those seen in the botanical world, with several classical descriptions firmly "implanted" into the dermatological canon.
